Results

Total Results: 2,064 records

Showing results for "year".

21. App-F2-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of serotonin–norepinephrine reuptake inhibitor versus placebo Author, Year Quality Pain Population … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk) Time

22. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year.

23. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
    January 01, 2023 - Each medication user was matched to two non- users on study site, birth year, gender and calendar year … The adjusted rate ratio for MI/SCD for current vs. remote use (> 1 year since last use) was 1.04 (95% … Covariates in the full model included study site, age (5-year dummy categories), gender, calendar year … During the year prior to baseline, several non-cardiovascular conditions, such as injury and asthma, … , year at t0 restricted to 1999-2005 Table A- 7.

24. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year. … Age is calculated as of December 31 of each year.

25. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk) Time … Harms of lidocaine patch versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk

26. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - million) of the overweight and obese population, approaches $3 billion a year. … $24 million per year to provider costs of performing these procedures. … The per-patient cost would be about $16,440 per year. … At this price, the cost of 1 year of lorcaserin treatment would be about $2,640. … We adopted a conservative estimate of 100,000 women undergoing lumpectomy each year.

27. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - However, the year- ly incidence rates varied little from 2006 to 2008. … and was continuously enrolled in the given year. … and identified with diabetes for that year. … and were identified with diabetes for that year. … Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

28. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.xlsx
    January 01, 2011 - 0.6 0.2 39.8% North American Native 2008 0.2 0.1 37.9% *Age is calculated as of Dec 31st of the year … (Algorithm 3: 12-month period of continuous enrollment and continuous FFS enrollment throughout the year … ) Breakdown Category Year Prevalence of LEA Rate of LEA in Enrolled Diabetic Population … ) Breakdown Category Year Prevalence of LEA In Enrolled Diabetic Population Rate of Major LEA … Rate of Minor LEA Rate of Major and Minor LEA in the same year Total All 2006 1.4% 0.5% 0.3% Age

29. App-F-Surv-Report-3-Acute-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f-surv-report-3-acute-pain.xlsx
    May 29, 2025 - Risk of bias assessment for randomized controlled trials Author, Year (Full Citations Are Listed in … , 2022 Yes Unclear Yes Unclear Unclear No Yes No/Yes No Yes; 11% Yes Poor Ilyas, 2021 No (by birth year … Parseliunas, 2021 Yes Unclear Yes Yes Yes Yes Yes No/No Yes No Yes Fair Paskey, 2021 No (by birth year

30. App-F-Surv-Report-2-Acute-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f-surv-report-2-acute-pain.xlsx
    May 29, 2025 - Risk of bias assessment for randomized controlled trials Author, Year (Full Citations Are Listed in … , 2022 Yes Unclear Yes Unclear Unclear No Yes No/Yes No Yes; 11% Yes Poor Ilyas, 2021 No (by birth year … Parseliunas, 2021 Yes Unclear Yes Yes Yes Yes Yes No/No Yes No Yes Fair Paskey, 2021 No (by birth year

31. App-F1-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Function outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class … Anxiety outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 … Depression outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class … Pain severity for fibroyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1

32. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - FFS plans, as defined in the Data Source section, and also continuously enrolled in the calendar year … and B FFS, as defined in the Data Source section, and also continuously enrolled in the calendar year … A beneficiary was included in the enroll- ment population for a given year if he or she had at least … and identified with diabetes for that year. … and identi- fied with diabetes for that year.

33. App-F1-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Function outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class … Anxiety outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 … Depression outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class … Pain severity for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1

34. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.xlsx
    January 01, 2011 - (Algorithm 3: 12-month period of continuous enrollment and continuous FFS enrollment throughout the year … ) Breakdown Category Year Incidence of Foot Ulcer In Enrolled Diabetic Population Incidence … 12.8% 3.8% North American Native 2008 7.0% 17.5% 5.0% *Age is calculated as of Dec 31st of the year … ) Breakdown Category Year Incidence of LEA In Enrolled Diabetic Population Incidence of … ) Breakdown Category Year Mortality Rates (number of beneficiaries who died in given year, divided

35. App-E-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveill-report-1.xlsx
    January 01, 2021 - RCT quality assessment Author, Year Randomization Adequate? Allocation Concealment Adequate? … Observational quality assessment Author, Year Did the Study Attempt To Enroll All (or a Random Sample … Case control quality assessment Author, Year Did the Study Attempt To Enroll All or Random Sample of

36. AHRQ's Evidence-based Practice Center Program: Annual Report 2024 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2024.pdf
    January 01, 2024 - /treatment-outcomes-chronic-kidney/rapid-research https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy … 2025-medicare-physician-fee-schedule-proposed-rule https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy … /treatment-outcomes-chronic-kidney/rapid-research https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy … 2025-medicare-physician-fee-schedule-proposed-rule https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy

37. App-F1-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug … Function outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class … Anxiety outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 … Depression outcomes for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class … Pain severity for fibromyalgia Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1

38. App-E-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-2.xlsx
    January 01, 2021 - RCT quality assessment Author, Year Randomization Adequate? Allocation Concealment Adequate? … Observational studies quality assessment Author, Year Did the Study Attempt To Enroll All (or a Random … Case control studies quality assessment Author, Year Did the Study Attempt To Enroll All or Random Sample

39. App-E-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-3.xlsx
    January 01, 2021 - RCT quality assessment Author, Year Randomization Adequate? Allocation Concealment Adequate? … Observational studies quality assessment Author, Year Did the Study Attempt To Enroll All (or a Random … Case control studies quality assessment Author, Year Did the Study Attempt To Enroll All or Random Sample

40. Angina-Heart-Attack-Treatments Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
    January 01, 2014 - In the United States, approximately 1.4 million people are diagnosed with ACS each year, and 70 percent … • After 1 year, ticagrelor was associated with lower composite ischemic endpoints (moderate SOE) … , all- cause mortality at 6 years, nonfatal MI at 1 year, stroke at 1 year, revascularization at 1 year … , stent thrombosis at 1 year, major bleeding at 1 year, and rehospitalization at 3 months. … Guidelines recommend a treatment duration of 1 year if there is no increased risk of bleeding.